Your browser doesn't support javascript.
T cells as the hoped-for savior for SARS-CoV-2 vaccination during CD20-depleting antibody therapy?: Commentary for: "Discordant humoral and T cell immune responses to SARS-CoV-2 vaccination in people with multiple sclerosis on anti-CD20 therapy."
Bsteh, Gabriel; Sellner, Johann.
  • Bsteh G; Department of Neurology, Medical University of Vienna, Vienna, Austria.
  • Sellner J; Department of Neurology, Landesklinikum Mistelbach-Gänserndorf, Mistelbach, Austria; Department of Neurology, Christian Doppler Medical Center, Paracelsus Medical Center, Salzburg, Austria; Department of Neurology, Klinikum rechts der Isar, Technische Universität München, München, Germany. Electronic address: Johann.Sellner@mistelbach.lknoe.at.
EBioMedicine ; 74: 103692, 2021 Dec.
Article in English | MEDLINE | ID: covidwho-1531185

Full text: Available Collection: International databases Database: MEDLINE Main subject: B-Lymphocytes / CD4-Positive T-Lymphocytes / CD8-Positive T-Lymphocytes / Antigens, CD20 / COVID-19 Vaccines / SARS-CoV-2 Topics: Vaccines Limits: Humans Language: English Journal: EBioMedicine Year: 2021 Document Type: Article Affiliation country: J.ebiom.2021.103692

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: B-Lymphocytes / CD4-Positive T-Lymphocytes / CD8-Positive T-Lymphocytes / Antigens, CD20 / COVID-19 Vaccines / SARS-CoV-2 Topics: Vaccines Limits: Humans Language: English Journal: EBioMedicine Year: 2021 Document Type: Article Affiliation country: J.ebiom.2021.103692